As part of the planning committee, I’m very pleased to share this year’s theme for the 2018 ISPE Quality Manufacturing Conference, June 4-6 in Arlington, VA: Manufacturing and Quality: Present and Future Opportunities to Ensure Continuous Improvement; and we have put together three very interesting and timely tracks on Regulatory, Quality and Manufacturing, and Facilities and Equipment topics.
One session that I am very excited about is the one centered on Contamination Control Strategies. The session will include perspectives from experts in the pharma industry and the U.S. FDA; and will delve into Contamination Control Strategies for sterile and non-sterile manufacturers as an essential consideration for preventing product contamination. Pharma industry experts will share successful ways to communicate and manage contamination controls, with real-life examples.
Attendees will also have a chance to participate in a Q&A session that poses questions such as:
I am really looking forward to attending this session as part of the 2018 ISPE Quality Manufacturing Conference and hope that you will join me in June.
Best Regards
The ISPE Quality Manufacturing Conference is the foremost pharmaceutical quality event of the year. It provides a unique forum for attendees and speakers from industry, academia, and regulatory to address areas for opportunities to assure innovation and continuous supply of high-quality products to our patients.
Here’s what you can expect:
Register by Monday, 26 March to take advantage of our lowest rates — saving you $400 or more!
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...